Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
This is comparable to the ~17.5% observed at 24 weeks in the Phase 2 obesity trial, reflecting the well-documented attenuation of weight loss in people with type 2 diabetes
Injecting in the evening may increase appetite suppression and metabolic activity during sleep, potentially causing restlessness or early morning waking
Published on June 13th, 2025
Nutrition also plays a key role
Current research gaps include long-term safety data, optimal dosing protocols for different populations, and comprehensive efficacy studies in diverse patient groups
The region of interest was chosen to calculate the intensity ratio changes in real-time
US$ 23.61
US$ 26.52
US$ 25.97
US$ 22.14
US$ 28.15
US$ 27.62
US$ 26.52
US$ 27.56
